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The region of tenascin-C containing only alternately spliced fibronectin type-III repeat D (fnD) increases neurite outgrowth by itself and
also as part of tenascin-C. We previously localized the active site within fnD to an eight amino acid sequence unique to tenascin-C,
VFDNFVLK, and showed that the amino acids FD and FV are required for activity. The purpose of this study was to identify the neuronal
receptor that interacts with VFDNFVLK and to investigate the hypothesis that FD and FV are important for receptor binding. Function-
blocking antibodies against both 7 and 1 integrin subunits were found to abolish VFDNFVLK-mediated process extension from
cerebellar granule neurons. VFDNFVLK but not its mutant, VSPNGSLK, induced clustering of neuronal 1 integrin immunoreactivity.
This strongly implicates FD and FV as important structural elements for receptor activation. Moreover, biochemical experiments re-
vealed an association of the 71 integrin with tenascin-C peptides containing the VFDNFVLK sequence but not with peptides with
alterations in FD and/or FV. These findings are the first to provide evidence that the71 integrin mediates a response to tenascin-C and
the first to demonstrate a functional role for the 71 integrin receptor in CNS neurons.
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Introduction
The extracellular matrix molecule tenascin-C exists as a family of
alternatively spliced variants with major actions to modulate
neuronal growth and migration (Bronner-Fraser, 1988; Gates et
al., 1996). Tenascin-C splice variants differ only in their number
of fibronectin type III (FN-III) repeats: all variants of human
tenascin-C have nine universal FN-III repeats, whereas the largest
splice variant has a series of alternatively spliced FN-III repeats
(fnA–D) that are missing in the smallest (see Fig. 1A). Periods of
increased axonal growth in the developing CNS have been closely
correlated with expression of large but not small tenascin-C (Crossin
et al., 1989; Tucker, 1993), suggesting that fnA–D might stimulate
neuronal growth during embryogenesis.
We and others (Gotz et al., 1996; Meiners and Geller, 1997)
have implicated alternatively spliced FN-III repeat D (fnD) as
providing the stimulus for neuronal process extension. We dem-
onstrated previously that a short linear amino acid sequence in
fnD derived from human tenascin-C, VFDNFVLK, is necessary
and sufficient for outgrowth promotion from cerebellar granule
neurons. Furthermore, FD and FV are critical for activity (Mein-
ers et al., 2001). The purpose of the current study was to identify
the neuronal receptor that interacts with VFDNFVLK and to
investigate the hypothesis that FD and FV are required for recep-
tor binding.
A comparison of VFDNFVLK in fnD and the corresponding
sequence EIDGIELT in universal FN-III repeat 3 (fn3) implicates
a 1 integrin as a candidate receptor for VFDNFVLK. The struc-
ture of fn3 has been reported previously (Leahy et al., 1992), and
EIDGIELT includes portions of an exposed loop and adjacent 
strand (see Fig. 1B). D in the exposed loop and E in the adjacent
 strand are required for binding to the integrin 91 (Yokosaki
et al., 1998). By analogy, it is likely that FD found in VFDNFVLK
is localized on an exposed loop in fnD for an interaction with
neurons, whereas FV is likely localized on a semi-buried strand,
in which it may lend conformational stability rather than binding
directly to neurons. However, it is unlikely that VFDNFVLK
binds to the 91 integrin, because 91 has not been detected
in brain (Huang et al., 2000).
We therefore explored the hypothesis that VFDNFVLK binds
to the 71 integrin, better known as a laminin-1 receptor in-
volved in neuromuscular (Burkin et al., 1998) and myotendinous
(Crawley et al., 1997) junctions. Tenascin-C is enriched at neu-
romuscular and myotendinous junctions (Chiquet and Fam-
brough, 1984; Cifuentes-Diaz et al., 2002), colocalizing it with
71. Moreover, mRNA transcripts for 7 integrin have been
found in many of the same brain regions as tenascin-C, including
the cerebellum (Pinkstaff et al., 1999). We now show that func-
tion blocking antibodies against both 7 and 1 integrin sub-
units abolished neurite outgrowth promotion by VFDNFVLK.
Ligand binding assays revealed an association of 71 with
tenascin-C peptides containing the VFDNFVLK sequence but
not peptides with alterations in FD and/or FV. These results in-
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dicate that the 71 integrin mediates a response to tenascin-C
and provide the first functional data on the role of 71 in CNS
neurons.
Materials and Methods
Proteins and antibodies. Recombinant wild-type and mutant fnD pro-
teins corresponding to alternatively spliced FN-III repeat D of human
tenascin-C were prepared as described previously (Meiners et al., 2001)
(Fig. 1). The mutant was created so that amino acid sequence FDNFV of
fnD was replaced by SPNGS. Synthetic peptides derived from the fnD
repeat of human tenascin-C were prepared by BioSynthesis (Lewisville,
TX). Peptides were characterized by the company using both mass spec-
tral analysis and HPLC tracing. Transfected baby hamster kidney cells
were a gift from Dr. Harold Erickson (Department of Cell Biology, Duke
University Medical Center, Durham, NC). Splice variants of human
tenascin-C were produced in the transfected cells (Aukhil et al., 1993).
Native large tenascin-C was purified from culture supernatants of these
cells by gelatin-Sepharose and hydroxyapatite chromatography (Aukhil
et al., 1993), followed by electroelution from nondenaturing gels (S.
Meiners, unpublished data). Purified mouse Engelbreth-Holm-Swarm
sarcoma laminin-1 and human serum fibronectin were from Invitrogen
(Rockville, MD).
Function-blocking hamster monoclonal antibodies against rat 1
(Ha2/5), rat 1 (Ha31/8), and rat 2 (Ha1/29) integrin chains were
purchased from PharMingen (San Diego, CA). Function-blocking ham-
ster monoclonal antibody against mouse 6 (GoH3) integrin chain was
purchased from Immunotech (Marseille, France). Function-blocking
mouse monoclonal antibody against rat 3 integrin chain (Ralph 3.1)
was developed by Dr. Louis Reichardt and obtained from the Develop-
mental Studies Hybridoma Bank [created under the auspices of the Na-
tional Institute of Child Health and Human Development and main-
tained by the University of Iowa, (Iowa City, IA)]. Function-blocking
mouse monoclonal O26 antibody against rat 7 integrin chain was
kindly provided by Dr. Stephen Kaufman (Department of Cell and Struc-
tural Biology, University of Illinois, Urbana, IL). Affinity-purified rabbit
polyclonal antibodies against the A and B cytoplasmic variants of mouse
7 integrin chain were kindly provided by Dr. Eva Engvall (The Burn-
ham Institute, La Jolla, CA). Rabbit polyclonal antibody against human
1 integrin chain was purchased from Santa Cruz Biotechnology (Santa
Cruz, CA). Rabbit polyclonal antibody against human full-length
tenascin-C was kindly provided by Dr. Harold Erickson.
Neuronal culture. Cerebellar granule neuronal cultures were prepared
from postnatal day 8 (P8) rat or P6 mouse pups as described previously
(Meiners et al., 2001). The pellet containing cerebellar granule neurons
was resuspended in neurobasal medium (NBM) (Invitrogen) supple-
mented with B27 (Invitrogen) plus 25 mM KCl plus 1% penicillin–strep-
tomycin (NBM/B27/KCl) and used for neurite outgrowth assays.
Neurite outgrowth assay. Neurite outgrowth, in response to fnD and its
neurite outgrowth-promoting peptide VFDNFVLK, as well as the extra-
cellular matrix molecules tenascin-C, laminin-1, and fibronectin, was
evaluated as follows. Poly-L-lysine (PLL)-coated glass coverslips in 24-
well trays were incubated with protein or peptide solutions (20 g/ml in
HBSS) overnight at 37°C. Excess solution was rinsed away with HBSS. Sub-
strate coating efficiencies were determined by incubating coverslips over-
night with proteins or peptides conjugated to N-hydroxysuccinimide-
fluorescein (Pierce, Rockford, IL). The fluorescence of proteins or peptides
bound to PLL-coated glass was then assessed as we described previously
(Meiners et al., 1999, 2001).
Cerebellar granule neurons were plated onto the coverslips containing
bound proteins or peptides at a density of 60,000 neurons per well. The
neurons were allowed to extend neurites for 24 hr in NBM/B27/KCl. To
study the effect of soluble peptide, VFDNFVLK was first bound to the
coverslips as described above; cerebellar granule neurons were then cul-
tured for 24 hr on the coverslips in medium containing an excess of
soluble peptide (300 nM). The extent of neurite outgrowth was then
determined using carboxyfluorescein diacetate (CFDA) labeling
(Petroski and Geller, 1994). CFDA (Sigma, St. Louis, MO) intensely
stains the soma and all processes of cultured, living neurons. Images of
the cultures were captured using a Macintosh Quadra 700 (Apple Com-
puters, Cupertino, CA) and analyzed with the NIH Image software. A
sample of 50 –75 neurons with well defined processes greater than one
cell soma was considered for each condition. Cultures were scored by
individuals blind to the treatment groups. The length of each primary
process and its branches was measured for each neuron, and the total
neurite length was calculated as the sum of the lengths of individual
neurites.
Antibody blocking experiments. The hypothesis that fnD and the VFD-
NFVLK peptide facilitate neuronal process extension via a 1 integrin
neuronal receptor was tested in neurite outgrowth experiments using a
function-blocking monoclonal antibody against rat 1 integrin chain.
FnD or VFDNFVLK (20 g/ml) were bound to PLL-coated glass cover-
slips overnight at 37°C, and excess solution was then washed away. Rat
cerebellar granule neurons were plated onto the coverslips in NBM/B27/
KCl and allowed to adhere for 1 hr. Hamster anti-rat 1 integrin chain
(0.5–100g/ml) was added to the cultures, and neurons were allowed to
extend processes for another 23 hr. In some cases, excess soluble VFDN-
FVLK was added immediately after plating the neurons, and1 antibody
was added 1 hr later. Neurons were then allowed to extend processes in
the presence of soluble peptide and 1 antibody for 23 hr.
To explore the identity of the  integrin chain partner for 1, we also
tested a panel of antibodies against  integrin subunits (0.5–100 g/ml)
for interference with neurite promotion by VFDNFVLK. This panel in-
cluded antibodies against rat1,2,3, and7 integrin chains, as well as
an antibody against mouse 6 integrin chain. The antibodies against rat
Figure 1. Structure of human tenascin-C. A, Organization of the tenascin-C molecule. This
diagram is adapted from Aukhil et al. (1993). The N termini of three arms are joined to form a
trimer, and two trimers are connected via a disulfide bond (S-S) to form a hexamer. Each arm
consists of 14 domains with homology to epidermal growth factor (EGF), 8 –17 FN-III repeats
depending on alternative RNA splicing, and a single fibrinogen (fbg) domain. The universal
FN-III repeats (fn1–5 and fn6 – 8) are present in all tenascin-C splice variants. The largest
tenascin-C splice variant contains nine alternatively spliced FN-III repeats (designated A1, A2,
A3, A4, B, AD1, AD2, C, and D, or fnA–D), which are missing in the shortest splice variant. B,
Crystal structure of universal tenascin-C FN-III domain 3 (fn3). This structure is adapted from
Leahy et al. (1992) and consists of six exposed loops and seven strands. The91 integrin
recognition sequence EIDGIELT, which corresponds to the neurite outgrowth-promoting se-
quence VFDNFVLK in fnD, is highlighted and includes portions of an exposed loop and adjacent
 strand.
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and mouse integrins were tested in assays using rat and mouse neurons,
respectively.
Immunocytochemistry for1 integrin chain. Potential clustering of a1
integrin neuronal receptor in response to VFDNFVLK and/or
VSPNGSLK was investigated using immunocytochemical techniques.
Rat cerebellar granule neurons were plated onto peptide-coated cover-
slips at a density of 60,000 neurons per well and cultured for 24 hr in
NBM/B27/KCl. Coverslips were fixed with acetic acid– ethanol
(5%–95%) for 10 min at20°C and incubated with monoclonal hamster
antibody against rat 1 integrin chain (10 g/ml), followed by a
fluorescein-conjugated goat anti-hamster secondary antibody (PharM-
ingen). All antibody dilutions were made in PBS containing 10% FCS.
The control for nonspecific binding of the secondary antibody was per-
formed by omitting the primary antibody in parallel cultures. Images of
the cultures were captured using a Macintosh Quadra 700.
Western blot analysis of 7 integrin chain in cerebellar granule neurons.
Expression of 7 integrin chain in rat cerebellar granule neurons was
examined using Western blotting techniques. Nitrocellulose paper from
Bio-Rad (Hercules, CA) was used for this and subsequent experiments.
Neurons were homogenized on ice in Laemmli sample buffer (Laemmli,
1970). The homogenate (25g) was subjected to SDS-PAGE (8%) (Lae-
mmli, 1970) under nonreducing conditions and Western blotting (Tow-
bin et al., 1979) with monoclonal O26 antibody, which cross-reacts with
all splice variants of rat 7 integrin, both extracellular and cytoplasmic
(Crawley et al., 1997), or polyclonal 7A or 7B antibodies, which spe-
cifically cross-react with variants containing either the A or B cytoplas-
mic tail (Vachon et al., 1997). Immunoreactive bands were visualized
using horseradish peroxidase-conjugated secondary antibodies and the
enhanced chemiluminescence method (ECL system; Amersham Bio-
sciences, Arlington Heights, IL).
Amplification of 7 integrin isoforms by reverse transcription-PCR. To
further explore neuronal expression of extracellular and cytoplasmic 7
integrin splice variant(s), PCR was performed as described previously
(Ziober et al., 2002) on reverse transcribed total RNA isolated from rat
cerebellar granule neurons. Total RNA was isolated using the RNeasy
mini kit according to the instructions of the manufacturer Qiagen, Santa
Clarita, CA). Reverse transcription (RT) of total RNA was done using 10
g of RNA, random primers, and reverse transcriptase according to the
instructions of the manufacturer (Pharmacia, Piscataway, NJ). For each
set of PCR reactions, negative controls, which lacked reverse transcrip-
tase or total RNA, were always included.
Primers used in the amplification of the X1 extracellular variant of the7
integrin subunit were X1/X2 antisense primer 5-CTATCCTTGCGC-
AGAATGAC-3 and X1 sense primer 5-GCCAGGGTGGAGCTCTG-3;
primers for amplification of the X2 extracellular variant were X1/X2 anti-
sense primer 5-CTATCCTTGCGCAGAATGAC-3 and X2 sense primer
5-GTGACCAACATTGATAGCTC-3; primers used in the amplification of
the A cytoplasmic variant were AB antisense primer 5-CACCGGATGT-
CCATCAGGAC-3 and either AB sense primer 5-GCTGCTCAGAGAT-
GCATCC-3 or A sense primer 5-CGGAACAGTCCAAGCTCCTCA-3;
primers used in the amplification of the B cytoplasmic variant were AB
antisense primer 5-CACCGGATGTCCATCAGGAC-3 and AB sense
primer 5-GCTGCTCAGAGATGCATCC-3. (The AB antisense primer
used in combination with the AB sense primer amplifies both A and B vari-
ants, whereas the A sense primer is specific for A.) These primers are based on
the sequence of mouse7 integrin; X1/X2 antisense, X1 sense, X2 sense, AB
antisense, and AB sense were used previously to amplify 7 integrin PCR
products from reverse-transcribed total RNA isolated from both rat and
mouse tissues (Ziober et al., 2002).
Preparation of neuronal cell extracts. Cerebellar granule neuronal ex-
tracts were prepared using methods adapted from published protocols
(Kramer et al., 1991; Gu et al., 1994). Cerebellar granule neurons were
plated in 35 mm PLL-coated tissue culture dishes in NBM/B27/KCl at a
density of 2  10 6 cells per dish. After 24 hr in culture, neurons were
washed three times with cold PBS and scraped on ice into PBS (100l per
plate of cells) containing 1% protease inhibitor mix for mammalian cells
(PBS; Sigma). The extracts were pooled and pelleted by centrifugation
at 20,000  g for 30 min. The pellet was then resuspended in buffer A
(200 mM n-octyl--D-glucopyranoside, 0.05% Triton X-100, 1% pro-
tease inhibitor mix, and 100 mM Tris-HCl, pH 7.4) (100 l per plate of
cells) and incubated on a rotary shaker for 1 hr at 4°C. The mixture was
centrifuged at 20,000  g, and the supernatant was adjusted to 2 mM
CaCl2 and used for tensacin-C peptide affinity chromatography.
Tenascin-C peptide affinity chromatography. To establish binding of
the 71 integrin to the neurite outgrowth-promoting motif in the fnD
repeat of tenascin-C, ligand binding experiments using affinity chroma-
tography were performed with D5 peptide (Meiners et al., 2001). D5
(complete sequence, VFDNFVLKIRDTKKQ), which contains the VFD-
NFVLK sequence and also promotes neurite outgrowth via VFDNFVLK
(Meiners et al., 2001), was used in these experiments instead of VFDN-
FVLK itself because it is more hydrophilic and readily soluble. This al-
lowed us to use a higher concentration of peptide (100g/ml, as opposed
to the 20 g/ml VFDNFVLK used in the neurite outgrowth experiments
described above) in the affinity chromatography experiments.
D5 peptide was coupled to cyanogen bromide-activated Sepharose
(Amersham Biosciences, Piscataway, NJ) at 100 g/protein/ml beads
according to the instructions of the manufacturer. To evaluate the con-
tribution of the conserved residues FD and FV to integrin binding, D5
peptides with amino acid substitutions in FD and/or FV were also con-
jugated to beads. The altered D5 peptides included D5 mutant 1
(VSPNGSLKIRDTKKQ), D5 mutant 2 (VSPNFVLKIRDTKKQ), and D5
mutant 3 (VFDNGSLKIRDTKKQ). Unreacted sites on the beads were
blocked with 1 M ethanolamine-HCl, pH 8.0. Uncoupled but blocked
Sepharose served as a negative control. Peptide-conjugated and control
Sepharose beads were equilibrated with 10 ml of buffer A (50 mM n-octyl-
-D-glucopyranoside, 50 mM Tris-HCl, pH 7.4, and 2 mM CaCl2). Each
type of Sepharose (250l) was then added to 500l of cerebellar granule
neuronal extract and incubated on a rotary shaker for 16 hr at 4°C.
Sepharose– cerebellar protein complexes were pelleted at low speed
(3000 g) and washed six times with buffer A and then two times with
buffer A containing 50 mM NaCl. The beads were eluted three times with
200 l washes of 10 mM EDTA in buffer A (without CaCl2). The EDTA
eluates were immediately adjusted to 20 mM CaCl2 and dialyzed over-
night at 4°C against buffer B (0.1% SDS, 10 mM Tris-HCl, 0.02% protease
inhibitor, and 2 mM CaCl2, pH 7.2). The presence of71 integrin in the
eluates was tested by Western blotting with monoclonal O26 antibody
against 7 integrin chain and polyclonal 1 integrin chain antibody.
Results
Neurite outgrowth promotion by FnD and VFDNFVLK is
mediated by a neuronal1 integrin
We first investigated whether fnD and its neurite-outgrowth pro-
moting sequence VFDNFVLK interact with a neuronal 1 inte-
grin to facilitate process extension. PLL-coated glass coverslips
were incubated with HBS alone (control) or with fnD or VFDN-
FVLK peptide (20 g/ml) overnight at 37°C. Substrate coating
efficiencies were 4.3 0.9 pmol/cm 2 for VFDNFVLK and 7.1
0.5 pmol/cm 2 for fnD under these conditions. Rat cerebellar
granule neurons were plated onto the coverslips and allowed to
extend neurites for 24 hr. In some conditions, a hamster mono-
clonal function-blocking antibody against rat 1 integrin chain
(0.5–100 g/ml) was added 1 hr after plating neurons and then
included during the remaining 23 hr of the experiment. [Adding
the 1 antibody at the same time as plating the neurons impaired
neuronal adhesion to fnD and VFDNFVLK, whereas adding an-
tibody 1 hr later had no obvious effect on adhesion (data not
shown).] The extent of neurite outgrowth was then assessed.
Distributions of total neurite length for neurons cultured on
each substrate are presented in Figure 2A. FnD and VFDNFVLK
both enhanced neurite growth compared with the PLL control, as
we showed previously (Meiners et al., 2001). The1 antibody did
not alter the distribution of total neurite lengths on PLL but
eliminated the enhancement of neurite outgrowth by fnD and
VFDNFVLK. Hence, the 1 integrin antibody specifically
blocked outgrowth promoted beyond the control level by fnD
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and VFDNFVLK but did not alter the basal level of growth on the
control substrate. Interactions of matrix molecules with integrins
have been primarily attributed to sites that have an Arg-Gly-Asp
(RGD) sequence (Ruoslahti, 1996). Our data suggest that a 1
integrin mediates promotion of neurite outgrowth by VFDN-
FVLK in fnD, which is a non-RGD sequence, much as a 1 inte-
grin mediates cell attachment to the corresponding non-RGD
sequence (EIDGIELT) in fn3 (Yokosaki et al., 1998).
Inhibition of outgrowth on fnD and VFDNFVLK was dose
dependent, with the maximal effect observed at 5–10 g/ml an-
tibody (data not shown); the illustrated results (Fig. 2A) were
obtained using 10 g/ml antibody. No inhibition of outgrowth
was observed when an anti-hamster IgM isotype control anti-
body was used instead of the 1 integrin antibody (data not
shown). Identical results were obtained using D5 (VFDNFV-
LKIRDTKKQ), a 15 amino acid peptide derived from fnD that
contains the VFDNFVLK sequence and promotes neurite out-
growth to the same extent as VFDNFVLK (Meiners et al., 2001)
(data not shown). The fact that outgrowth on the tenascin-C-
derived molecules in the presence of the 1 antibody was indis-
tinguishable from control suggests that negligible process exten-
sion occurred during the first hour of the experiment, before the
addition of the antibody.
We showed that VFDNFVLK promotes outgrowth when
bound as well as when soluble (Meiners et al., 2001). Therefore,
the ability of the 1 antibody to block the effects of soluble VFD-
NFVLK was also evaluated. Peptide was first bound to coverslips,
and excess peptide in solution (300 nM) was added. Neurons were
then plated onto the coverslips and cultured in the presence of
bound plus soluble peptide. Figure 2B demonstrates that the
addition of soluble VFDNFVLK significantly enhanced out-
growth compared with values obtained on bound VFDNFVLK
alone (Fig. 2A), as reported previously (Meiners et al., 2001).
Neurite outgrowth on bound plus excess soluble VFDNFVLK
was reduced to control levels in the presence of 1 antibody.
Identical results were obtained using bound plus excess soluble
fnD or D5 instead of VFDNFVLK (data not shown). This suggests
that the substrate bound and soluble protein and peptide use the
same receptor system.
Integrin activation requires receptor clustering as well as li-
gand binding (Tran et al., 2002). We therefore investigated the
ability of VFDNFVLK to induce clustering of 1 integrin sub-
units in growing neurites. Peptide was bound to PLL-coated cov-
erslips, and cerebellar granule neurons were plated onto the cov-
erslips and cultured for 24 hr. They were then reacted with an
antibody against 1 integrin chain. Neurons cultured on VFDN-
FVLK demonstrated punctate clusters of integrin immunoreac-
tivity on the cell soma, neuritic processes, and growth cones com-
pared with neurons cultured on PLL. On the other hand, neurons
cultured on VSPNGSLK, which does not promote neurite out-
growth (Meiners et al., 2001), failed to demonstrate similar clus-
ters despite a higher substrate coating efficiency for VSPNGSLK
as opposed to VFDNFVLK (10.2  1.4 pmol/cm 2 for
VSPNGSLK vs 4.3  0.9 pmol/cm 2 for VFDNFVLK) (Fig. 3).
Similar negative results were obtained using a VASNAGLK pep-
tide instead of VSPNGSLK, although the amino acid substitu-
tions in VASNAGLK were more conservative than those in
VSPNGSLK (data not shown). These results suggest that VFDN-
FVLK can activate a 1 integrin neuronal receptor and that the
residues FD and FV are required for receptor activation.
The7 integrin subunit is implicated as the partner for 1
We investigated the possibility that the7 integrin subunit acts as
the partner for 1 to mediate neurite outgrowth responses to
VFDNFVLK (Bartsch et al., 1992; Pinkstaff et al., 1999). 7 is
alternatively spliced in both the extracellular and cytoplasmic
domains, giving rise to two extracellular (X1 and X2) and two
predominant cytoplasmic (A and B) variants (Ziober et al., 2002).
Our first step was to conduct a Western blot analysis to establish
whether rat cerebellar granule neurons in fact express the 7
integrin and, if so, which splice variant(s). Using monoclonal
O26 antibody (which cross-reacts with all splice variants of the7
integrin subunit), a single polypeptide band was identified on
blots with Mr of 120,000 (Fig. 4A). This polypeptide is of the
correct size to represent the intact 7 chain (Gu et al., 1994).
Identical results were obtained using polyclonal 7B antibody,
whereas no bands were visible using polyclonal 7A antibody.
Hence, cerebellar granule neurons express a variant of 7 inte-
grin with the B cytoplasmic tail.
We next conducted an RT-PCR analysis of the expression of
both cytoplasmic and extracellular 7 integrin variants in rat
cerebellar granule neurons. Amplification with a sense primer
specific for the X2 extracellular variant and an antisense primer
common to both X1 and X2 variants yielded a PCR product of
200 bp corresponding to the X2 isoform, whereas amplification
with a sense primer specific for the X1 variant and the antisense
Figure 2. A1 integrin neuronal receptor is implicated in promotion of neurite outgrowth
by fnD and VFDNFVLK. A, Rat cerebellar granule neurons were cultured for 24 hr on PLL-coated
glass coverslips in the presence of bound fnD or VFDNFVLK and a function-blocking antibody
against1 integrin subunit (10g/ml). Distributions of total neurite length are presented as a
box-and-whisker plot. One representative experiment of four is shown. Boxes enclose 25th and
75th percentiles of each distribution and are bisected by the median; whiskers indicate 5th and
95th percentiles. FnD and VFDNFVLK significantly enhanced outgrowth compared with the PLL
control (*p 0.05; Kolmogorov–Smirnov test). The1 integrin antibody did not alter neurite
outgrowth on PLL but completely blocked outgrowth promotion by fnD and VFDNFVLK. B,
Neurons were cultured for 24 hr on PLL-coated coverslips in the presence of bound plus excess
soluble (bd sl) VFDVFVLK and1 integrin antibody. One representative experiment of three
is shown. Outgrowth values were higher than those observed in A for neurons cultured on
bound peptide alone and reduced to control values in the presence of1 antibody.
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primer common to both X1 and X2 yielded no PCR product
corresponding to X1 (Fig. 4B). Furthermore, amplification with
sense and antisense primers common to both the A and B cyto-
plasmic variants yielded a single PCR product of 370 bp corre-
sponding to the B isoform; no PCR product corresponding to A
(480 bp) was observed, in agreement with the Western blot re-
sults (Fig. 4A). Another amplification was performed using a
second sense primer, this one specific to the A variant, in con-
junction with the same antisense primer. Again, no PCR product
corresponding to the A isoform was revealed. These results dem-
onstrate that cerebellar granule neurons express the X2B variant
of the 7 integrin subunit.
To explore whether the 7 integrin participates in the neuro-
nal response to VFDNFVLK, we tested the O26 antibody for
obstruction of neurite outgrowth promotion by the tenascin-C
peptide. VFDNFVLK was bound to PLL-coated coverslips, as
described in Materials and Methods. Rat cerebellar granule neu-
rons were plated onto control and peptide-coated coverslips and
cultured for 24 hr. O26 antibody (0.5–100 g/ml) was added in
some conditions 1 hr after the neurons were plated and included
during the remaining 23 hr of the experiment. Process extension
was then quantified. Figure 5 demonstrates that the O26 antibody
did not alter neurite outgrowth on PLL at any concentration used
but completely inhibited outgrowth promotion by VFDNFVLK
at 10 g/ml. Inhibition was biphasic, with less inhibition ob-
served at lower and higher antibody concentrations. This is rem-
iniscent of the biphasic inhibition of myoblast migration on
laminin-1 by the same antibody (Crawley et al., 1997) and may be
attributable to direct receptor blockade at lower antibody con-
centrations coupled with some receptor cross-linking at higher
antibody concentrations. The O26 antibody also blocked neurite
outgrowth promotion by soluble VFDNFVLK (data not shown).
Similar results were obtained using fnD or D5 instead of VFDN-
FVLK (data not shown). These data support the hypothesis that
the 7 integrin chain acts in concert with 1 to mediate neurite
outgrowth responses to VFDNFVLK.
Specificity of the O26 antibody, as well as the potential in-
volvement of other integrin subunits in VFDNFVLK-mediated
neurite promotion, was tested in outgrowth assays using
function-blocking antibodies against rat 1, 2, and 3 integrin
chains. Rat cerebellar granule neurons were plated onto control
and peptide-coated coverslips, and antibodies (0.5–100 g/ml)
were added 1 hr later. Neurons were cultured for an additional 23
hr. None of the antibodies altered the distributions of neurite
length on PLL or VFDNFVLK at 10 g/ml (Fig. 6A) or at any
other concentration tested (data not shown). Lacking an equiva-
lent antibody against rat 6 integrin, we also tested a function-
blocking antibody against mouse 6 integrin chain in neurite
outgrowth assays using mouse cerebellar granule neurons. This
antibody also failed to alter neurite outgrowth on PLL or VFDN-
FVLK (Fig. 6B). Furthermore, none of the antibodies blocked
neurite outgrowth by soluble VFDNFVLK (data not shown).
Identical results were obtained in these experiments using fnD or
Figure 3. Neurons cultured on bound VFDNFVLK but not VSPNGSLK demonstrate clustering
of immunoreactivity for 1 integrin subunit. Immunocytochemistry was performed using a
monoclonal hamster antibody against1 integrin chain, followed by a fluorescein-conjugated
goat anti-hamster secondary antibody. VFDNFVLK but not VSPNGSLK induced clustering of
neuronal1 integrin immunoreactivity. Scale bar, 10m.
Figure 4. Cerebellar granule neurons express the X2B isoform of the7 integrin subunit. A,
Homogenate from P8 rat cerebellar granule neurons (25g) was separated on 8% SDS-PAGE
gels under nonreducing conditions and then transferred to nitrocellulose paper. Blots were
probed with monoclonal O26 antibody, which cross-reacts with all splice variants of the 7
integrin chain, or polyclonal7A or7B antibodies, which cross-react with variants containing
the A or B cytoplasmic tail. Immunoreactive bands were visualized using the enhanced chemi-
luminescence method. Blots probed with the O26 or7B antibody demonstrated one predom-
inant polypeptide band with Mr of 120,000, whereas blots probed with the 7A antibody
revealed no polypeptide band. B, RT-PCR was performed on total RNA prepared from P8 rat
cerebellar granule neurons. Amplification was done using sense and antisense primers de-
signed to amplify X1, X2, A, and B variants of the 7 integrin as described in Materials and
Methods. The 200 bp fragment corresponds to the X2 extracellular variant, and the 370 bp
fragment corresponds to the B cytoplasmic variant. No products were obtained that corre-
sponded to the X1 extracellular variant (220 bp) or the A cytoplasmic variant (480 bp).
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D5 instead of VFDNFVLK (data not shown). Therefore, the 1,
2, 3, and 6 integrin subunits do not appear to be involved in
the facilitation of process extension by VFDNFVLK.
To investigate whether the 7 integrin interacts with native
tenascin-C to promote neurite outgrowth, rat cerebellar granule
neurons were plated onto PLL-coated coverslips containing
bound large tenascin-C splice variant. The large tenascin-C splice
variant used in this experiment contained the alternatively
spliced FN-III repeats A1, A2, A3, A4, B, C, and D but not AD2
nor AD1 (see Fig. 1A). O26 antibody was added after 1 hr, and
neurite lengths were measured after 23 hr. Large tenascin-C (sub-
strate coating efficiency 5.9 0.9 pmol/cm 2) supported consid-
erable process extension compared with PLL (Fig. 7A), which was
partially blocked by the O26 antibody. As with VFDNFVLK, in-
hibition of process extension on tenascin-C was biphasic (data
not shown), with the maximal inhibition at 10 g/ml O26 anti-
body (illustrated in Fig. 7). No inhibition of neurite outgrowth
was seen when small tenascin-C was used instead of large
tenascin-C (data not shown). These results suggest that VFDN-
FVLK forms a functional 7 integrin binding site in the intact
large tenascin-C protein and that other active sites and receptors
also mediate outgrowth responses to tenascin-C. In addition,
these results support our previous work indicating that the pep-
tide sequence is active in tenascin-C (Meiners et al., 2001).
Neurite outgrowth experiments were also conducted for cer-
ebellar granule neurons growing on a large tenascin-C substrate
in the presence of the function-blocking antibody against 1 in-
tegrin chain. The 1 antibody completely blocked outgrowth
promotion by tenascin-C (Fig. 7A), as reported previously by
Varnum-Finney et al. (1995). Varnum-Finney et al. (1995) also
demonstrated that a function-blocking antibody to 8 integrin
partially blocked outgrowth promotion by tenascin-C from em-
bryonic sensory and motor neurons and completely blocked out-
growth promotion by fn6 – 8, another tenascin-C region that
supports neuronal process extension when substrate bound
(Varnum-Finney et al., 1995; Meiners and Geller, 1997). Like
embryonic sensory and motor neurons, rat cerebellar granule
neurons express 8 integrin, as determined by RT-PCR analysis
(data not shown). Therefore, large tenascin-C may promote neu-
rite outgrowth via interactions with two neuronal 1 integrins:
7l and 81.
We then tested the O26 antibody for interference with out-
growth promotion by the extracellular matrix molecules
laminin-1 and fibronectin. Laminin-1 and fibronectin (20 g/
Figure 5. The7 integrin subunit is implicated as the partner for1 in promotion of neurite
outgrowth by VFDNFVLK. Rat cerebellar granule neurons were cultured for 24 hr on PLL-coated
glass coverslips in the presence of bound VFDNFVLK and function-blocking O26 antibody
against7 integrin subunit (100, 50, 10, 5, 1, or 0.5g/ml). One representative experiment of
three is shown. VFDNFVLK significantly enhanced outgrowth compared with the PLL control
(*p 0.05; Kolmogorov–Smirnov test). The 7 integrin antibody did not alter neurite out-
growth on PLL at any concentration used. The antibody inhibited promotion of outgrowth by
VFDNFVLK and demonstrated a biphasic concentration dependence. Outgrowth was signifi-
cantly impaired at 50, 10, and 5g/ml O26 antibody (**p 0.05; Kolmogorov–Smirnov test),
with maximal inhibition at 10g/ml.
Figure 6. The 1, 2, 3, and 6 integrin subunits do not play a role in VFDNFVLK-
facilitated neurite growth. Rat cerebellar granule neurons were cultured for 24 hr on PLL-coated
coverslips in the presence of bound VFDNFVLK and function-blocking antibodies against 1,
2, or3 integrin subunits (10g/ml) ( A), whereas mouse cerebellar granule neurons were
cultured in the presence of bound VFDNFVLK and a function-blocking antibody against 6
integrin subunit (10g/ml) ( B). One representative experiment of three is shown. VFDNFVLK
significantly enhanced outgrowth compared with PLL (*p 0.05; Kolmogorov–Smirnov test).
None of the antibodies altered neurite outgrowth on PLL or VFDNFVLK.
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ml) were bound to PLL-coated coverslips. Rat cerebellar granule
neurons were plated onto the coverslips, and O26 antibody was
added 1 hr later. After an additional 23 hr in culture, the extent of
neurite outgrowth was assessed. Laminin-1 and fibronectin (with
substrate coating efficiencies of 8.2  1.4 and 6.5  0.9 pmol/
cm 2, respectively) both facilitated process extension compared
with PLL (Fig. 7B). The O26 antibody had no effect on neurite
outgrowth on fibronectin but partially blocked neurite out-
growth promotion by laminin-1. This suggests that the 7 inte-
grin does not mediate neurite outgrowth responses to fibronectin
but is perhaps one of several neuronal receptors mediating out-
growth responses to laminin-1.
The71 integrin binds to VFDNFVLK-containing peptides
in an FD–FV-dependent manner
We next investigated whether the neurite outgrowth-promoting
motif in tenascin-C can biochemically associate with 71 inte-
grin derived from rat cerebellar granule neurons. To do this,
ligand binding assays were performed using affinity chromatog-
raphy with D5 and modified D5 peptides conjugated to Sepha-
rose beads. As mentioned in Materials and Methods, D5 peptide
was used instead of VFDNFVLK because it is more hydrophilic
and readily soluble, allowing for the conjugation of a larger
amount of protein. The modified peptides included D5 mutant 1
(FD and FV substituted with SP and GS), D5 mutant 2 (FD sub-
stituted with SP), and D5 mutant 3 (FV substituted with GS).
These peptides, based on those used previously to identify critical
residues in fnD and VFDNFVLK for neurite outgrowth promo-
tion (Meiners et al., 2001), fail to facilitate neuronal process ex-
tension (data not shown).
Neuronal proteins were extracted as described in Materials
and Methods using n-octyl--D-glucopyranoside and Triton
X-100. Wild-type D5- and D5 mutant-conjugated Sepharose
beads were then incubated with the neuronal extract to allow any
integrin binding to occur, washed, and eluted with EDTA. The
presence of 7 and 1 integrin subunits in the eluates was as-
sessed by Western blotting with O26 antibody and polyclonal 1
integrin antibody. Both integrin subunits were detected on West-
ern blots for material eluted from wild-type D5-conjugated beads
but not for material eluted from D5 mutant 1-conjugated beads
(Fig. 8A) or from D5 mutant 2 or D5 mutant 3-conjugated beads
(data not shown). No 7 or 1 polypeptide bands were observed
when control Sepharose was substituted for D5-conjugated
Sepharose (data not shown).
Silver-stained gels of proteins eluted from wild-type D5 pep-
tide (Fig. 8B) revealed predominant overlapping polypeptide
bands with Mr of 120,000 and 116,000, corresponding to the
relative mobilities of the bands recognized by the O26 and 1
integrin antibodies. The appearance of these overlapping bands is
typical and has been reported previously (Crawley et al., 1997).
The bands were not detected for proteins eluted from D5 mutant
1 peptide (Fig. 8B), D5 mutant 2 or D5 mutant 3 peptide (data
not shown), or control Sepharose (data not shown). The Western
blot and silver stain data indicate that neuronal 71 integrin
binds specifically to the D5 peptide and that FD and FV are crit-
ical for the association, just as they are both required for neurite
outgrowth promotion by fnD, D5, and VFDNFVLK (Meiners et
al., 2001). The same conclusion is supported by the fact that
incubation of neuronal proteins with wild-type D5 peptide fol-
lowed by immunoprecipitation with 1 integrin antibody re-
sulted in the presence of1 integrin subunit,7 integrin subunit,
and peptide in the immunoprecipitate, whereas substitution of
D5 mutant peptide for wild-type D5 peptide resulted in no pep-
tide in the immunoprecipitate (data not shown). In other affinity
chromatography experiments, integrin binding was also detected
to fnD and large tenascin-C (data not shown). This supports the
antibody blocking results of Figure 7 and indicates that the 71
binding site is not cryptic in native tenascin-C.
Discussion
The fnD repeat of tenascin-C facilitates neurite extension in cul-
ture by itself and as part of intact tenascin-C (Meiners et al.,
2001). Tenascin-C splice variants containing this domain are
preferentially expressed during periods of increased axonal
growth in the developing CNS (Joester and Faissner, 1999), sug-
gesting that fnD also stimulates neuronal growth in vivo. Previous
work showed that the sequence VFDNFVLK derived from hu-
man tenascin-C was necessary and sufficient for neurite out-
growth promotion by fnD (Meiners et al., 2001). This study
shows that function-blocking antibodies against 7 and 1 inte-
grin subunits eliminate the neuronal response to VFDNFVLK
and that 71 binds to tenascin-C peptides containing VFDN-
FVLK. This is the first demonstration that 71 integrin medi-
Figure 7. 7 integrin is involved in neurite outgrowth promotion by tenascin-C and
laminin-1 but not by fibronectin. A, Rat cerebellar granule neurons were cultured for 24 hr on
PLL-coated coverslips in the presence of bound large tenascin-C and function-blocking antibody
O26 against7 integrin subunit or function blocking antibody against1 integrin subunit. One
representative experiment of three is shown. Tenascin-C significantly enhanced outgrowth
compared with PLL (*p 0.05; Kolmogorov–Smirnov test). The7 antibody partially blocked
outgrowth promotion by large tenascin-C; the reduction in outgrowth values was significant
(**p 0.05; Kolmogorov–Smirnov test). The 1 integrin antibody completely blocked out-
growth promotion by large tenascin-C. B, Rat cerebellar granule neurons were cultured for 24 hr
on PLL-coated coverslips in the presence of bound laminin-1 or fibronectin and function-
blocking O26 antibody against7 integrin subunit. One representative experiment of three is
shown. Laminin-1 and fibronectin significantly enhanced outgrowth compared with PLL (*p
0.05; Kolmogorov–Smirnov test). The 7 antibody partially reduced neurite outgrowth on
laminin-1; the reduction was significant (**p 0.05; Kolmogorov–Smirnov test). The anti-
body did not alter neurite outgrowth on fibronectin.
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ates a response to tenascin-C and the first functional data on the
role of 71 in CNS neurons.
Neurite outgrowth promotion from cerebellar granule neu-
rons by native tenascin-C was partially but not wholly blocked by
the 7 antibody (Fig. 7A), suggesting that 71 forms a func-
tional interaction with tenascin-C as well as VFDNFVLK. This
also suggests that tenascin-C sequences outside of VFDNFVLK
promote neurite outgrowth via other receptors. fn6 – 8, as noted
above, facilitates process extension via 81 integrin (Varnum-
Finney et al., 1995), and fnB–D promotes outgrowth via F3/con-
tactin but only when fnB and fnD are not interrupted by fnC
(Rigato et al., 2002). Accordingly, it is possible that amino acids in
fnB and fnD form an active site for neurite extension and F3/
contactin binding only when the two FN-III repeats are adjacent
to one another, a spatial coordination that cannot occur in the
presence of fnC. The RGD site in fn3 binds to v3 integrin
(Joshi et al., 1993; Sriramarao et al., 1993), but fn3 does not
promote outgrowth from CNS neurons (Phillips et al., 1995;
Gotz et al., 1996; Meiners and Geller, 1997). Together with the1
integrin blocking data (Fig. 7A), it seems likely that the fnC-
containing tenascin-C splice variant used in this study promotes
neurite outgrowth via two sites–receptors: fn6 – 8 and 81, and
VFDNFVLK and 71.
Similar to the results with tenascin-C, laminin-1-facilitated
cerebellar granule neuron process extension was partially
blocked by the 7 antibody. Because 1 is the only known inte-
grin subunit binding partner for 7 (Hynes, 1992), this indicates
that 71 encourages cerebellar granule neurites to grow longer
on laminin-1 as well as tenascin-C. The partial block observed
was likely attributable to the fact that several integrins, not just
71, act together to mediate outgrowth responses to laminin-1.
For example, 31 and 61, which are both expressed in cerebel-
lum (Pinkstaff et al., 1999), recognize RGD- and IKLLI-containing
neurite-promoting sequences, respectively, in laminin-1 (Tomaselli
et al., 1990; Tashiro et al., 1991). The amino acid sequence in
laminin-1 that binds to 71 remains to be determined, but
laminin-1 does not contain a sequence homologous to VFDNFVLK.
Furthermore, a VFDNFVLK-containing peptide did not elute71
integrin bound to laminin-1 (data not shown).
The 71 integrin has also been shown to bind to the RGD
motif of fibronectin (Gu et al., 1994). Fibronectin, like tenascin-C
and laminin-1, promoted neurite outgrowth from cerebellar
granule neurons in this study. However, the 7 antibody did not
block outgrowth responses to fibronectin. This implies that71
and RGD do not interact to facilitate cerebellar granule neuronal
process extension on fibronectin, just as they do not appear to
interact to mediate myoblast adhesion or migration on fibronec-
tin (Crawley et al., 1997). Like myoblast interactions with fi-
bronectin, neurite outgrowth may rely instead on another
fibronectin-binding integrin, such 51.
We showed previously that VFDNFVLK overcomes chon-
droitin sulfate proteoglycan (CSPG)-mediated impairment of
neurite outgrowth (Meiners et al., 2001). CSPGs are upregulated
on glial scars (McKeon et al., 1991), and the preponderance of
evidence indicates that they are inhibitory to axonal regrowth
after CNS injury (Gates et al., 1996; Zuo et al., 1998). Hence,
VFDNFVLK may have a potential role in regenerative strategies.
Function-blocking7 and1 antibodies eliminated the ability of
VFDNFVLK to increase outgrowth on CSPGs (Meiners, unpub-
lished data), suggesting that neuronal receptor activation, and
not stearic hindrance of CSPGs by the peptide, was responsible
for the actions of VFDNFVLK. It thus appears that VFDNFVLK
increases neurite length in the absence and presence of CSPGs via
interactions with 71.
Neurons in the developing CNS are capable of substantial
neurite regeneration (Bandtlow and Loschinger, 1997), whereas
neurons in the adult CNS normally do not regenerate (Plunet et
al., 2002). That VFDNFVLK increases neurite outgrowth from
early postnatal neurons via interactions with an integrin has im-
portant implications for its utility in therapeutic strategies. We
and others (Davies et al., 1997; Meiners et al., 1999; Chen et al.,
2000) have suggested that an inhibitory environment with a pau-
city of growth-promoting molecules, matrix derived or other-
Figure 8. Neuronal71 integrin binds to D5 peptide in an FD–FV-dependent manner. P8
cerebellar granule neuronal extracts were incubated with Sepharose beads conjugated with
either wild-type D5 peptide (D5 wt) or D5 mutant 1 peptide with alterations in both FD and FV
(D5 mt). A, Proteins eluted with EDTA from wild-type or mutant D5 peptide were separated on
8% SDS-PAGE gels under nonreducing conditions and transferred to nitrocellulose paper. Blots
were probed with monoclonal O26 antibody against7 integrin chain or polyclonal antibody
against1 integrin chain. Immunoreactive bands were visualized using the enhanced chemi-
luminescence method. Blots of proteins eluted with EDTA from D5 wt peptide revealed polypep-
tide bands with Mr of 120,000 and 116,000, respectively, for the O26 and1 integrin antibod-
ies. Blots of proteins eluted with EDTA from D5 mt peptide revealed no polypeptide bands. B,
Silver-stained gels revealed overlapping polypeptide bands with Mr of 120,000 and 116,000 for
proteins eluted with EDTA from D5 wt peptide but not D5 mt 1 peptide.
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wise, contributes to failed regeneration in the adult CNS. How-
ever, a reduced number of receptors for growth-promoting
molecules on adult versus young neurons may also play a major
role. In support of this idea, adult dorsal root ganglion neurons,
which do not regenerate their central processes, demonstrated
low integrin expression and poor process extension on laminin-1
and fibronectin compared with early postnatal neurons. Increas-
ing the expression of 1 or 5 integrins in adult neurons by gene
transfer methods resulted in greatly enhanced neurite outgrowth
on laminin-1 and fibronectin, respectively (Condic, 2001).
Hence, maximal neurite regrowth in the injured adult CNS will
probably involve a strategy to increase expression of integrins and
other key receptors in damaged neurons, as well as provision of a
regeneration mixture of growth-promoting molecules such as
VFDNFVLK.
Like embryonic CNS neurons, adult PNS neurons are capable
of extensive neurite regeneration (Plunet et al., 2002). Here again,
successful regeneration is closely correlated with the induction of
neuronal integrins. For example, embryonic peripheral neurons,
and perhaps adult peripheral neurons as well, can adapt to CSPG
inhibition of neurite outgrowth by increasing their expression of
31 and 61 integrins (Condic et al., 1999). Furthermore,
elevated expression of 4 (Vogelezang et al., 2001) and 71
(Werner et al., 2000) integrins in adult wild-type mice has been
connected to the successful regrowth of damaged peripheral neu-
ronal processes. 7 knock-out mice demonstrated impaired ax-
onal regrowth and delayed target reinnervation in the facial nerve
(Werner et al., 2000), suggesting that 71 is absolutely critical
for regeneration in the PNS. Significantly, 71 was not in-
creased after central nerve injury, leaving open the question of
whether low expression of this and other integrins is a limiting
factor in CNS regeneration.
Laminin-1 was suggested to be the neurite outgrowth-
promoting ligand for 71 in the PNS (Werner et al., 2000).
However, tenascin-C, like laminin-1, is upregulated after PNS
injury and is appropriately localized to provide growth-
promoting cues to regenerating neurites (Kuecherer-Ehret et al.,
1990; Martini et al., 1990; Yip et al., 1995; Zhang et al., 1995).
Moreover, work in frog (Mege et al., 1992) and mouse
(Langenfeld-Oster et al., 1994) using function-blocking antibod-
ies to tenascin-C to interrupt its function in vivo showed that, as
in the 7 knock-out mouse, target reinnervation was greatly de-
layed or inhibited. In light of our current results, it seems likely
that tenascin-C as well as laminin-1 could be a peripheral ligand
for 71 integrin.
On the other hand, closer examination suggests that
tenascin-C may play more of a guidance role as opposed to an
outgrowth-promoting role after PNS trauma. For example, ax-
onal regrowth did in fact occur in the frog study (Mege et al.,
1992) and the tenascin-C knock-out mouse (Cifuentes-Diaz et
al., 2002), but the paths that the regrowing nerves traveled were
altered compared with controls. We showed that tenascin-C pro-
vides independent outgrowth-promoting and guidance cues to
cerebellar granule neurites in vitro (Meiners et al., 1999). There-
fore, these studies indicate that other molecules such as laminin-1
may compensate for some outgrowth-promoting functions nor-
mally provided by tenascin-C in vivo but not its ability to guide
peripheral neurites by confining them to specific paths. Although
we have not as of yet determined a role for 1 integrins in
tenascin-C-mediated guidance of cerebellar granule neuronal
processes, potential involvement of the 71 in tenascin-C-
mediated guidance of PNS axons remains to be investigated.
In conclusion, we showed that enhancement of neuronal pro-
cess extension by tenascin-C and the tenascin-C-derived se-
quence VFDNFVLK is eliminated by function-blocking antibod-
ies against both 7 and 1 integrin subunits. Alteration of the
conserved residues FD and FV destroys the ability of 71 to
associate with the peptide, indicating that these amino acids are
important for receptor binding. We suggested previously that
VFDNFVLK might find applicability as a reagent to promote
neurite growth in otherwise inhibitory environments (Meiners et
al., 2001). Given that 71 is increased in neurons after PNS but
not CNS injury (Werner et al., 2000), our results suggest that
manipulating the expression of this receptor in damaged CNS
neurons might improve their ability to regenerate in response to
reagents such as VFDNFVLK.
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